Using brain stimulation to treat neuropathic pain
Official title: Combining Functional Magnetic Resonance Imaging and Transcranial Direct Current Stimulation to Investigate Pain-related Brain Networks in Patients With Neuropathic Pain
Run by National Taiwan University Hospital · NCT06237075 · Data updated 2026-11-12
This study is testing whether a brain stimulation technique can help people with neuropathic pain feel better by looking at how it affects their brain activity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 90 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | September 11, 2023 |
| Main results expected | September 11, 2030 |
| Study ends | September 11, 2030 |
| Registry record updated | February 1, 2024 |
| Trial ID | NCT06237075 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 20 to 90 with confirmed neuropathic pain due to peripheral neuropathy.
✕Probably not a fit
Patients with severe systemic diseases, major neurological disorders, or significant mental health issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project investigates the effects of transcranial direct current stimulation (tDCS) on neuropathic pain caused by peripheral neuropathy. The study employs a unique approach by combining tDCS with functional magnetic resonance imaging (fMRI) to observe the brain's response during stimulation. The primary targets for stimulation are the primary motor cortex and the dorsolateral prefrontal cortex. The goal is to enhance understanding of how tDCS can modulate pain-related brain networks and potentially improve treatment strategies for patients suffering from neuropathic pain.
Why it matters
Potential benefit: If successful, this approach could provide a novel non-invasive treatment option for patients with neuropathic pain who are unresponsive to conventional therapies.
How similar studies have gone: While the combination of tDCS and fMRI is a relatively novel approach, previous studies have shown promise in using tDCS for pain management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Age 20 or older and 90 or younger. 2. Ability to give informed consent 3. Neuropathic pain and/or nonpainful sensory symptoms resulted from I or II I. Peripheral neuropathy confirmed by clinical symptoms nerve conduction study, autonomic function test, quantitative sensory test, or skin biopsy. II. Stroke involving somatosensory pathway confirmed by neuroimage 4. Agree not to take caffeine, alcohol, tea and drugs with significant nervous system effects for 48 hours before each study session. Exclusion Criteria: * 1\. Presence of sever systemic diseases, including severe ischemic heart disease or congestive heart failure (left ventricular ejection fraction \< 30%), severe lung diseases with dyspnea, severe generalized edema, and systemic infection 2. Presence of major neurological disorders, including brain tumor, head trauma and infection or inflammation of nervous system. 3\. Presence of major depression or any major mental disorders 4. Presence of a cardiac pacemaker, brain stimulator, aneurysm clips or metal implants in the head, unless these devices are certified to be MRI-compatible 5. Pregnancy 6. Claustrophobia or any other contraindications to MRI 7. Inability to give informed consent.
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Sung-Tsang Hsieh, MD, PhD
- Email: shsieh@ntu.edu.tw
- Phone: (886)-2- 2-2312-3456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Extended-release Pregabalin for nerve pain from diabetes or shingles
This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.
-
High-Intensity Peripheral Magnetic Stimulation for Traumatic Nerve Injury
This study tests whether adding high-intensity peripheral magnetic stimulation to a structured exercise program can reduce pain and improve function for adults with a traumatic peripheral nerve injury.
-
Hematological clues and how patients respond to nerve blocks for neuropathic pain
This study looks at blood inflammation markers to see if they relate to how well people with neuropathic pain respond to sympathetic nerve blocks.
-
Cord plasma eye drops to treat neuropathic corneal pain
This trial will test whether cord plasma eye drops can reduce long-lasting nerve-related corneal pain in people with evidence of corneal nerve damage.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.